Apatinib in refractory radiation-induced brain edema: A case report

RATIONALE: Apatinib is a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor-2, which has observed to be effective and safe in refractory radiation-induced brain edema, like Avastin did. Till now, there is no case report after apatinib came in the market. PATIENT CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Wei Guo, Weng, Yi Ming, Dong, Yi, Li, Xiang Pan, Song, Qi-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
6100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704783/
https://www.ncbi.nlm.nih.gov/pubmed/29145238
http://dx.doi.org/10.1097/MD.0000000000007358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704783/
https://www.ncbi.nlm.nih.gov/pubmed/29145238
http://dx.doi.org/10.1097/MD.0000000000007358

Ejemplares similares